Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Muscle weakness precedes atrophy during cancer cachexia and is linked to muscle-specific mitochondrial stress
Luca J. Delfinis, Catherine A. Bellissimo, Shivam Gandhi, Sara N. DiBenedetto, Madison C. Garibotti, Arshdeep K. Thuhan, Stavroula Tsitkanou, Megan E. Rosa-Caldwell, Fasih A. Rahman, Arthur J. Cheng, Michael P. Wiggs, Uwe Schlattner, Joe Quadrilatero, Nicholas P. Greene, Christopher G.R. Perry
Luca J. Delfinis, Catherine A. Bellissimo, Shivam Gandhi, Sara N. DiBenedetto, Madison C. Garibotti, Arshdeep K. Thuhan, Stavroula Tsitkanou, Megan E. Rosa-Caldwell, Fasih A. Rahman, Arthur J. Cheng, Michael P. Wiggs, Uwe Schlattner, Joe Quadrilatero, Nicholas P. Greene, Christopher G.R. Perry
View: Text | PDF
Research Article Metabolism Oncology

Muscle weakness precedes atrophy during cancer cachexia and is linked to muscle-specific mitochondrial stress

  • Text
  • PDF
Abstract

Muscle weakness and wasting are defining features of cancer-induced cachexia. Mitochondrial stress occurs before atrophy in certain muscles, but the possibility of heterogeneous responses between muscles and across time remains unclear. Using mice inoculated with Colon-26 cancer, we demonstrate that specific force production was reduced in quadriceps and diaphragm at 2 weeks in the absence of atrophy. At this time, pyruvate-supported mitochondrial respiration was lower in quadriceps while mitochondrial H2O2 emission was elevated in diaphragm. By 4 weeks, atrophy occurred in both muscles, but specific force production increased to control levels in quadriceps such that reductions in absolute force were due entirely to atrophy. Specific force production remained reduced in diaphragm. Mitochondrial respiration increased and H2O2 emission was unchanged in both muscles versus control while mitochondrial creatine sensitivity was reduced in quadriceps. These findings indicate muscle weakness precedes atrophy and is linked to heterogeneous mitochondrial alterations that could involve adaptive responses to metabolic stress. Eventual muscle-specific restorations in specific force and bioenergetics highlight how the effects of cancer on one muscle do not predict the response in another muscle. Exploring heterogeneous responses of muscle to cancer may reveal new mechanisms underlying distinct sensitivities, or resistance, to cancer cachexia.

Authors

Luca J. Delfinis, Catherine A. Bellissimo, Shivam Gandhi, Sara N. DiBenedetto, Madison C. Garibotti, Arshdeep K. Thuhan, Stavroula Tsitkanou, Megan E. Rosa-Caldwell, Fasih A. Rahman, Arthur J. Cheng, Michael P. Wiggs, Uwe Schlattner, Joe Quadrilatero, Nicholas P. Greene, Christopher G.R. Perry

×

Figure 6

Schematic representation of energy homeostasis in states of low metabolic (left) versus high metabolic (right) demand.

Options: View larger image (or click on image) Download as PowerPoint
Schematic representation of energy homeostasis in states of low metaboli...
When ADP is low, less ATP is produced. A concomitant accumulation of [H+] in the inner membrane space (IMS) increases membrane potential (ΔΨ), attenuates [H+] pumping, induces premature electron slip, and generates superoxide (O2•–), which is dismutated to H2O2 by manganese superoxide dismutase (MnSOD; top left). Only complex I–derived O2•– is displayed. When ADP is high, more ATP is produced as [H+] diffuses from the IMS to the mitochondrial matrix through ATP synthase. The decrease in ΔΨ lowers premature electron slip, generating less O2•– and H2O2 (top right). ADP generated by ATPases throughout the cell enter the matrix through the voltage dependent anion channel (VDAC) on the outer mitochondrial membrane (OMM) and the adenine nucleotide translocase (ANT) on the inner mitochondrial membrane (IMM; bottom left). Creatine accelerates matrix ADP/ATP cycling and ATP synthesis by reducing the diffusion distance of the slower diffusing ADP and ATP while shuttling phosphate to the cytoplasm through rapidly diffusing phosphocreatine (PCr), which is used by cytosolic creatine kinase (cCK) to recycle local ATP to support the activity of various ATPases. Rapidly diffusing creatine returns to the IMS to be rephosphorylated by mitochondrial creatine kinase (mtCK). Non-ATPase sites of ATP hydrolysis are not displayed but also contribute to net metabolic demand (kinases and other ATP-dependent processes). The net effect of metabolic demand (global ATP hydrolysis) on matrix ADP/ATP cycling is displayed under the context of creatine-independent (-creatine) and creatine-dependent (+creatine) conditions. Figure adapted from Aliev et al., 2011; Guzun et al., 2012; Wallimann et al., 2011; and Nicholls and Ferguson, 2013 (23, 50–52). Created with BioRender.com.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts